Benedetto Falsini

This study is testing a new type of eye drop called CHF6467, a 'painless' nerve growth factor, to see if it can protect and improve vision in children and young adults (ages 3-40) with optic pathway glioma. The goal is to prevent the vision loss that often occurs with this type o…